Acasă › Leucemie acută bifinotipică › Washington › Seattle
Studii clinice pentru Leucemie acută bifinotipică în Seattle, WA
15 studii pentru Leucemie acută bifinotipică caută participanți în și în jurul orașului Seattle (în aproximativ 50 km). Deschideți un studiu pentru a vedea criteriile de eligibilitate și cum să contactați echipa de cercetare.
Text oficial al studiului (în engleză)
A Phase 1 Study of Orca-Q in Recipients Undergoing Allogeneic Transplantation for Hematologic Malignancies
În curs de recrutareFaza 1
- Fred Hutchinson Cancer Center, Seattle
Testing the Addition of the Anti-cancer Drug Venetoclax and/or the Anti-cancer Immunotherapy Blinatumomab to the Usual Chemotherapy Treatment for Infants With Newly Diagnosed KMT2A-rearranged or KMT2A-non-rearranged Leukemia
În curs de recrutareFaza 2
- Seattle Children's Hospital, Seattle
CLAG-M or FLAG-Ida Chemotherapy and Reduced-Intensity Conditioning Donor Stem Cell Transplant for the Treatment of Relapsed or Refractory Acute Myeloid Leukemia, Myelodysplastic Syndrome, or Chronic Myelomonocytic Leukemia
În curs de recrutareFaza 1
- Fred Hutch/University of Washington Cancer Consortium, Seattle
Randomization for the Identification of Best Treatment Intensity for Less Fit Adults With Acute Myeloid Leukemia and Myeloid Neoplasms
În curs de recrutare
- Fred Hutch/University of Washington Cancer Consortium, Seattle
Inotuzumab Ozogamicin and Post-Induction Chemotherapy in Treating Patients With High-Risk B-ALL, Mixed Phenotype Acute Leukemia, and B-LLy
În curs de recrutareFaza 3
- Seattle Children's Hospital, Seattle
The Pediatric Acute Leukemia (PedAL) Screening Trial - A Study to Test Bone Marrow and Blood in Children With Leukemia That Has Come Back After Treatment or Is Difficult to Treat - A Leukemia & Lymphoma Society and Children's Oncology Group Study
În curs de recrutareFaza 1/2
- Seattle Children's Hospital, Seattle
Cord Blood Transplant, Cyclophosphamide, Fludarabine, and Total-Body Irradiation in Treating Patients With High-Risk Hematologic Diseases
În curs de recrutareFaza 2
- Fred Hutch/University of Washington Cancer Consortium, Seattle
Combination Chemotherapy (FLAG-Ida) Followed Immediately by Reduced-Intensity Total Body Radiation Therapy and Donor Hematopoietic Cell Transplant for the Treatment of Adults Age 60 and Older With Newly Diagnosed Adverse-Risk Acute Myeloid Leukemia or Other High-Grade Myeloid Cancer
În curs de recrutareFaza 2
- Fred Hutch/University of Washington Cancer Consortium, Seattle
211^At-BC8-B10 Before Donor Stem Cell Transplant in Treating Patients With High-Risk Acute Myeloid Leukemia, Acute Lymphoblastic Leukemia, Myelodysplastic Syndrome, or Mixed-Phenotype Acute Leukemia
În curs de recrutareFaza 1/2
- Fred Hutch/University of Washington Cancer Consortium, Seattle
211At-BC8-B10 Followed by Donor Stem Cell Transplant in Treating Patients With Relapsed or Refractory High-Risk Acute Leukemia or Myelodysplastic Syndrome
În curs de recrutareFaza 1/2
- Fred Hutch/University of Washington Cancer Consortium, Seattle
Donor Stem Cell Transplant With Treosulfan, Fludarabine, and Total-Body Irradiation for the Treatment of Hematological Malignancies
În curs de recrutareFaza 2Voluntari sănătoși bineveniți
- Fred Hutch/University of Washington Cancer Consortium, Seattle
HA-1 T TCR T Cell Immunotherapy for the Treatment of Patients With Relapsed or Refractory Acute Leukemia After Donor Stem Cell Transplant
În curs de recrutareFaza 1
- Fred Hutch/University of Washington Cancer Consortium, Seattle
Chemotherapy (Decitabine in Combination With FLAG-Ida) and Total-Body Irradiation Followed by Donor Stem Cell Transplant for the Treatment of Adults With Myeloid Malignancies at High Risk of Relapse
În curs de recrutareFaza 1/2Voluntari sănătoși bineveniți
- Fred Hutch/University of Washington Cancer Consortium, Seattle
Venetoclax and CLAG-M for the Treatment of Acute Myeloid Leukemia and High-Grade Myeloid Neoplasms
În curs de recrutareFaza 1/2
- Fred Hutch/University of Washington Cancer Consortium, Seattle
Tagraxofusp in Pediatric Patients With Relapsed or Refractory CD123 Expressing Hematologic Malignancies
În curs de recrutareFaza 1
- Seattle Children's Hospital, Seattle
Studii pentru Leucemie acută bifinotipică în alte orașe
- Houston, TX11 studii
- New York City, NY10 studii
- Atlanta, GA9 studii
- Durham, NC8 studii
- Memphis, TN7 studii
- Chicago, IL7 studii
- Charlotte, NC6 studii
- Aurora, CO6 studii
- Baldwin Park, CA6 studii
- Portland, OR6 studii
- Los Angeles, CA6 studii
- Philadelphia, PA6 studii
Alte studii în Seattle
- Cancer pulmonar cu celule non-pătrate53 studii
- Cancer (toate tipurile)49 studii
- Cancer de prostată42 studii
- Leucemie mieloasă acută40 studii
- Cancer de sân39 studii
- Cancer metastatic39 studii
- Cancer colorectal34 studii
- Cancer pulmonar33 studii
- Cancer ovarian30 studii
- Mielom multiplu22 studii
- Sindroame mielodisplastice21 studii
- Leucemie limfoblastică acută21 studii
Sursă: ClinicalTrials.gov, date preluate la 5 oct. 2026. Fiecare studiu are propriile criterii de eligibilitate; echipa de cercetare decide cine poate participa.